Following the launch of participant enrolment in Thailand in June 2026, the ELDORADO team carried out an early initiation visit to the three participating study sites.
The visits provided an opportunity to meet the local teams and Principal Investigators, strengthen collaboration, clarify patient pathways and address outstanding questions related to study implementation.
At each site, the team reviewed the patient pathway and visited the laboratories and pharmacies involved in the trial.
The visits took place at:
• Lampang Hospital – 6 July
• Phayao Hospital – 6 July
• Chiangrai Prachanukroh Hospital – 7 July
These early site visits are an important step in supporting smooth trial implementation and ensuring that study procedures are well understood and adapted to each clinical setting.
